Hansen Medical, Inc. (HNSN)

Future of surgery. Entering with caution.

Current 3.12, Sept 17 09. Limit 3.06

Pick from EV38's blog and fransgeraedts

stock is a serious gift at 4 a share.As a thoracic surgeon I can personally attest to the sensei system's magnificent performance.One is also assured by Dr, Moll's guidance and assurance of the continual updating and improvements going forward.I.m all in.

> The Sensei is a dangerous piece of equipment for patients, leading to 17-19% complication rates.

> Dr. Fred Moll has lost all credibility after promising "slam dunk" guidance of 53-60 systems in 2009, after only delivering 3 in Q2 (conveniently after they pushed a secondary in April, have you.)

> Hansen's gross margins have eroded to close to 0% as ASPs have collapsed due to the lack of a value proposition.

> Hansen needs to completely restructure and reengineer its product for use in electrophysiology to be adopted clinically. A 17F sheath is too big for the vasculature, in particular, the femoral artery.

> Hansen has suffered the loss of talent, with spontaneous resignations from the President and COO, Gary Restani, to members of the board and key engineering talent.

The new health care plan will undoubtably return Hansen to double digit numbers.They had a bad last quarter,but almost everyone did.Look for Hansen to clean up all debt and get a huge push from the health care plan

Alternate profile for stocks I want to track seperately.

Medical robots, inside buying

won the lawsuit, good positioning

Undervalued, just won $36MM suit v. LUNA

Today they signed a deal with GE Healthcare. It will boost their sales all over the world.

Early days, reminiscent of ISRG. Several insiders have recently brought lots of shares

Indsider buying, RB.

Rule Breaker, beat down by the current market.

22% insider ownership and only 28% institutional. They've had negative EPS the last 7 quarters and its projected to continue for the future 2-5…they just reduced guidance for 2009, even further delaying profitability. Yes its far off its 52 week high and there has been lots of insider buying lately. They've been burning through cash almost as fast as the US government, and just had to offer up some stock, diluting shares, because they need more. Hospitals aren't going to be spending like crazy anytime soon. I think they are too far behind with other companies already out with safe and effective products, I don't think hansen can make it. Going bye bye.

Good price, near 52 week low. Robotics & less invasive surgery are two medical trends that will continue to grow IMHO. 3D Imaging is also a high growth market. Well run company at a great discount, I'd say it's a obvious buy.

Assets have grown considerably while the liabilities only increase slightly. Like the cash on hand as well.

patient died recently during Hansen procedure

With nearly 1/5 procedures with the sensei system having sometimes life-threatening complications and top executives of the company threatening to split (and go somewhere else)... this company and it's product seems to be defective. I wouldn't put my money on this company.